Clinical research regulation in India-history, development, initiatives, challenges and controversies: Still long way to go
Open Access
- 1 January 2013
- journal article
- review article
- Published by Medknow in Journal of Pharmacy and Bioallied Sciences
- Vol. 5 (1) , 2-9
Abstract
The Central Drugs Standard Control Organisation and its chairman Drug Controller general of India are bequeathed to protect the citizens from the marketing of unsafe medication. The startling findings, of the 59 th report of the Parliamentary Standing Committee on Health and Family Welfare, have uncovered the lax standards followed by the regulatory authorities in India. The growing clinical research after the product patents rights for the pharmaceutical industries as per the trade related aspects of intellectual property rights agreement and adverse drug reaction monitoring of the marketed drugs have raised many ethical and regulatory issues regarding the promotion of new drugs in Indian markets. Many controversial group of medicines; unauthorised and irrational FDCs not relevant to India's medical needs, are available which are not sold in any of the countries with matured regulatory bodies. It becomes vital to understand the history, growth and evolution of the regulatory aspects of drugs which are handled by multiple Ministries and Departments of the Government of India. Although amendment to Schedule Y, registration of Contract Research Organisations, registration of Clinical Trials, Speeding up review process, Pharmacovigilance (PhV) programme for India and Inspection of clinical trial sites have been started by the various regulatory agencies. However due to casual approach in marketing approval for sale of the drugs, the unethical steps taken by some pharmaceutical companies and medical practitioners has reiterated the need to get appropriate understanding of present regulation of drugs and clinical research especially regarding the practical rules and regulations.Keywords
This publication has 18 references indexed in Scilit:
- Indian clinical trials: Paradigm shift from speed to quality?Perspectives in Clinical Research, 2012
- The health of European medical researchEMBO Reports, 2011
- Integrated monitoring: Setting new standards for the next decade of clinical trial practicePerspectives in Clinical Research, 2011
- Intellectual property rights: An overview and implications in pharmaceutical industryJournal of Advanced Pharmaceutical Technology & Research, 2011
- Quality of independent review board/ethics committee oversight in clinical trials in IndiaPerspectives in Clinical Research, 2011
- How to minimize low enrolling sites: A case study in diabetesPerspectives in Clinical Research, 2010
- Clinical trials in India: ethical concernsBulletin of the World Health Organization, 2008
- Clinical trials in IndiaPharmacological Research, 2007
- Ethical and legal issues in research involving human subjects: do you want a piece of me?Journal of Clinical Pathology, 2006
- The GATT TRIPS Agreement and health care in India.1995